We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar.

Pfizer (NYSE:PFE) shares slid about 3% on Tuesday morning after the company lowered its earnings and revenue forecasts for 2026. The pharmaceutical giant now expects earnings per share between $2.80 ...

Fintel reports that on December 15, 2025, B of A Securities maintained coverage of Pfizer (NYSE:PFE) with a Neutral ...

Pfizer on ​Tuesday ‌forecast 2026 profit ‌below Wall Street estimates, sending its ⁠shares ‌down 1. The ‍drugmaker expects ...

The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.

Shares in Pfizer ($PFE) inched higher early Tuesday even as the U.S. pharma giant forecast 2026 earnings that are below Wall ...

Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.

Pfizer (NYSE:PFE) shares slid about 5% on Tuesday morning after the company lowered its earnings and revenue forecasts for 2026. The pharmaceutical giant now expects earnings per share between $2.80 ...

Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...

Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.

Pfizer projected 2026 adjusted earnings per share of $2.80 to $3, below analysts’ expectations of $3.05.